Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Scientists working to understand why men with prostate cancer are at higher risk of Alzheimer’s

Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer

Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent...

Precision therapy for metastatic prostate cancer improves survival

Precision therapy for metastatic prostate cancer improves survival

New hope for prostate cancer: new form of immunotherapy could prevent resistance to hormone therapy

New hope for prostate cancer: new form of immunotherapy could prevent resistance to hormone therapy

Prostate cancer test is missing early disease in transgender women

Prostate cancer test is missing early disease in transgender women

Improving prostate cancer screening for transgender women

Improving prostate cancer screening for transgender women

ASCO 2024: Trastuzumab deruxtecan significantly improves progression-free survival In breast cancer patients previously treated with endocrine therapy

ASCO 2024: Trastuzumab deruxtecan significantly improves progression-free survival In breast cancer patients...

ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower risk

ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower...

Shaping the future of neuroendocrine tumour management

Shaping the future of neuroendocrine tumour management

Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer

Adding chemotherapy to hormone therapy helps control locally advanced prostate cancer

More from ecancer